Nu-Med Plus, Inc. financial data

Symbol
NUMD on OTC
Location
Port Jefferson, NY
Fiscal year end
31 December
Latest financial report
10-K - Q4 2024 - 31 Mar 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 11% %
Debt-to-equity -113% %
Return On Assets -655% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83,548,469 shares 0%
Common Stock, Shares, Outstanding 83,548,469 shares 0%
Entity Public Float $3,235,074 USD 271%
Common Stock, Value, Issued $83,549 USD 0%
Weighted Average Number of Shares Outstanding, Basic 81,348,469 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 81,348,469 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $9,467 USD 7%
Operating Income (Loss) $17,417 USD -15%
Nonoperating Income (Expense) $1,260 USD 0%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $18,677 USD -14%
Net Income (Loss) Attributable to Parent $68,345 USD 46%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,373 USD -65%
Assets, Current $9,373 USD -30%
Assets $9,373 USD -30%
Accounts Payable, Current $43,040 USD 432%
Accrued Liabilities, Current $14,719 USD 145%
Liabilities, Current $224,469 USD 40%
Liabilities $224,469 USD 40%
Retained Earnings (Accumulated Deficit) $9,893,332 USD -0.7%
Stockholders' Equity Attributable to Parent $215,096 USD -47%
Liabilities and Equity $9,373 USD -30%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $450 USD 98%
Common Stock, Shares Authorized 90,000,000 shares 0%
Common Stock, Shares, Issued 83,548,469 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $450 USD 98%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,373 USD -65%
Deferred Tax Assets, Valuation Allowance $2,266,924 USD 3.1%
Property, Plant and Equipment, Gross $83,893 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $2,266,924 USD 3.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $9,594,687 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $1,247 USD 1.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%